Clinical Trials Browser

Phase 2 × Has announcements × tisotumab vedotin × Clear all

NCT03438396 2023-07-25

A Trial of Tisotumab Vedotin in Cervical Cancer

Phase 2 Completed

102 enrolled 20 charts 1 FDA

Uterine Cervical Neoplasms